{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:21:29Z","timestamp":1793298089059,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007175","name":"National Council for Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Foundation of France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.atherosclerosis.2024.118596","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:00:54Z","timestamp":1726243254000},"page":"118596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The singular French PCSK9-p.Ser127Arg gain-of-function variant: A significant player in cholesterol levels from a 775-year-old common ancestor"],"prefix":"10.1016","volume":"399","author":[{"given":"Yara","family":"Azar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Le Bon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea Bismo","family":"Str\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bluteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Di-Filippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Carri\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedi","family":"Chtioui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"B\u00e9liard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriane","family":"Marmontel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Fonteille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite","family":"Gebhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00ebl","family":"Peretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Ferri\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Pradignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Farnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Yelnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"G\u00e9nin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Pr\u00f8ven","family":"Bogsrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond P.","family":"Leren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Abifadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Rab\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9261-1551","authenticated-orcid":false,"given":"Mathilde","family":"Varret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2024.118596_bib1","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects","volume":"75","author":"Beheshti","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib2","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.atherosclerosis.2018.08.010","article-title":"High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: the French Familial Hypercholesterolemia Registry","volume":"277","author":"B\u00e9liard","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib4","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM197606172942509","article-title":"Familial hypercholesterolemia: a genetic defect in the low-density lipoprotein receptor","volume":"294","author":"Brown","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib5","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0022-2275(20)42605-7","article-title":"Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia","volume":"31","author":"Innerarity","year":"1990","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/humu.22215","article-title":"Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation","volume":"34","author":"Marduel","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MOL.0000000000000496","article-title":"Familial hypercholesterolemia: experience from France","volume":"29","author":"Rab\u00e8s","year":"2018","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib9","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.3390\/ijms23105792","article-title":"APOE molecular spectrum in a French cohort with primary dyslipidemia","volume":"23","author":"Abou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2021.02.022","article-title":"Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993-2020","volume":"322","author":"Leren","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0021-9150(98)00267-6","article-title":"Fine mapping of low-density lipoprotein receptor gene by genetic linkage on chromosome 19p13.1-p13.3 and study of the founder effect of four French Canadian low-density lipoprotein receptor gene mutations","volume":"143","author":"Couture","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s004390050243","article-title":"Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations","volume":"98","author":"Steyn","year":"1996","journal-title":"Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1172\/JCI115839","article-title":"The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland","volume":"90","author":"Koivisto","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib14","first-page":"443","article-title":"A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews","volume":"49","author":"Meiner","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib15","doi-asserted-by":"crossref","first-page":"E682","DOI":"10.1002\/humu.21002","article-title":"The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene","volume":"30","author":"Abifadel","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.atherosclerosis.2021.01.008","article-title":"Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries","volume":"319","author":"Futema","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib17","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/s41598-018-20281-9","article-title":"New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia","volume":"8","author":"Elbitar","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib18","article-title":"The PCSK9 discovery, an inactive protease with varied functions in hypercholesterolemia, viral infections, and cancer","volume":"62","author":"Seidah","year":"2021","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051550","article-title":"In silico insights into protein-protein interaction disruptive mutations in the PCSK9-LDLR complex","volume":"21","author":"Martin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41467-017-00568-7","article-title":"Heparan sulfate proteoglycans present PCSK9 to the LDL receptor","volume":"8","author":"Gustafsen","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib21","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.celrep.2015.11.006","article-title":"GRP94 regulates circulating cholesterol levels through blockade of PCSK9-induced LDLR degradation","volume":"13","author":"Poirier","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib22","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1074\/jbc.M116.744235","article-title":"Endoplasmic reticulum stress and Ca2+ depletion differentially modulate the sterol regulatory protein PCSK9 to control lipid metabolism","volume":"292","author":"Lebeau","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/BJ20130930","article-title":"PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulum","volume":"457","author":"Str\u00f8m","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.tem.2018.03.013","article-title":"Beyond LDL: what role for PCSK9 in triglyceride-rich lipoprotein metabolism?","volume":"29","author":"Dijk","year":"2018","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1194\/jlr.M087189","article-title":"Cell-associated heparin-like molecules modulate the ability of LDL to regulate PCSK9 uptake","volume":"60","author":"Galvan","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.960272","article-title":"Pathogenic gain-of-function mutations in the prodomain and C-terminal domain of PCSK9 inhibit LDL binding","volume":"13","author":"Sarkar","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib27","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/01.ATV.0000133684.77013.88","article-title":"Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9","volume":"24","author":"Ouguerram","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.ATV.0000155323.18856.a2","article-title":"Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production","volume":"25","author":"Millar","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.atherosclerosis.2007.07.022","article-title":"Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa","volume":"196","author":"Homer","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib30","doi-asserted-by":"crossref","first-page":"28856","DOI":"10.1074\/jbc.M109.037085","article-title":"Dissection of the endogenous cellular pathways of PCSK9-induced low density lipoprotein receptor degradation: evidence for an intracellular route","volume":"284","author":"Poirier","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib31","article-title":"Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia","volume":"S1933287423002271","author":"Darabi","year":"2023","journal-title":"J. Clini. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib32","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/ATVBAHA.120.314482","article-title":"Novel PCSK9 (proprotein convertase subtilisin kexin type 9) variants in patients with familial hypercholesterolemia from Cape Town","volume":"41","author":"Huijgen","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib33","first-page":"266","article-title":"PCSK 9 gain-of-function mutations (R496W and D374Y) and clinical cardiovascular characteristics in a cohort of Turkish patients with familial hypercholesterolemia","volume":"18","author":"Kaya","year":"2017","journal-title":"Anatol. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib34","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3389\/fgene.2020.01020","article-title":"PCSK9 variants in familial hypercholesterolemia: a comprehensive synopsis","volume":"11","author":"Guo","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosissup.2017.07.002","article-title":"Spectrum of mutations in Italian patients with familial hypercholesterolemia: new results from the LIPIGEN study","volume":"29","author":"Pirillo","year":"2017","journal-title":"Atherosclerosis Suppl."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCGENETICS.115.001129","article-title":"Characterization of autosomal dominant hypercholesterolemia caused by PCSK9 gain of function mutations and its specific treatment with alirocumab, a PCSK9 monoclonal antibody","volume":"8","author":"Hopkins","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib37","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1086\/302370","article-title":"A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32","volume":"64","author":"Varret","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib38","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41431-017-0078-y","article-title":"Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?","volume":"26","author":"Ghaleb","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib39","doi-asserted-by":"crossref","first-page":"E1811","DOI":"10.1002\/humu.21348","article-title":"Molecular spectrum of autosomal dominant hypercholesterolemia in France","volume":"31","author":"Marduel","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib40","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2015.03.003","article-title":"Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales","volume":"240","author":"Haralambos","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib41","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/jmg.2003.017962","article-title":"Estimating the age of rare disease mutations: the example of Triple-A syndrome","volume":"41","author":"Genin","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib42","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1542\/peds.2011-0449","article-title":"Novel modeling of reference values of cardiovascular risk factors in children aged 7 to 20 years","volume":"129","author":"Mellerio","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib43","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jacl.2017.05.007","article-title":"Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: age- and gender-specific baseline lipid values and percentiles","volume":"11","author":"Balder","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.atherosclerosis.2012.04.006","article-title":"Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia","volume":"223","author":"Abifadel","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng1509","article-title":"Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9","volume":"37","author":"Cohen","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib46","article-title":"Human generation times across the past 250,000 years","volume":"9","author":"Wang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/geno.1997.4898","article-title":"Estimation of the age of the ancestral Arginine3500\u2192 glutamine mutation in human ApoB-100","volume":"45","author":"Myant","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0021-9150(99)00470-0","article-title":"Familial defective apolipoprotein B-100: a mutation emerged in the mesolithic ancestors of Celtic peoples?","volume":"148","author":"Miserez","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib49","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jacl.2019.04.099","article-title":"The island of Gran Canaria: a genetic isolate for familial hypercholesterolemia","volume":"13","author":"S\u00e1nchez-Hern\u00e1ndez","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411319","article-title":"Age, origin and functional study of the prevalent LDLR mutation causing familial hypercholesterolaemia in gran Canaria","volume":"24","author":"Su\u00e1rez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib51","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1194\/jlr.P119000173","article-title":"PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults","volume":"60","author":"Mefford","year":"2019","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2020.106804","article-title":"Treatment with PCSK9 inhibitors induces a more anti-atherogenic HDL lipid profile in patients at high cardiovascular risk","volume":"135","author":"Ingueneau","year":"2020","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.118596_bib54","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024011687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024011687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T15:20:04Z","timestamp":1732807204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024011687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":53,"alternative-id":["S0021915024011687"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118596","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The singular French PCSK9-p.Ser127Arg gain-of-function variant: A significant player in cholesterol levels from a 775-year-old common ancestor","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"118596"}}